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Abstract: Bifunctional FAD synthases (FADSs) catalyze FMN (flavin mononucleotide) and
FAD (flavinadenine dinucleotide) biosynthesis at their C-riboflavin kinase (RFK) and N-FMN:
adenylyltransferase (FMNAT) modules, respectively. Biophysical properties and requirements for their
FMNAT activity differ among species. Here, we evaluate the relevance of the integrity of the binding
site of the isoalloxazine of flavinic substrates for FMNAT catalysis in Corynebacterium ammoniagenes
FADS (CaFADS). We have substituted P56 and P58, belonging to a conserved motif, as well as L98.
These residues shape the isoalloxazine FMNAT site, although they are not expected to directly contact
it. All substitutions override enzyme ability to transform substrates at the FMNAT site, although
most variants are able to bind them. Spectroscopic properties and thermodynamic parameters for the
binding of ligands indicate that mutations alter their interaction modes. Substitutions also modulate
binding and kinetic properties at the RFK site, evidencing the crosstalk of different protomers within
CaFADS assemblies during catalysis. In conclusion, despite the FMNAT site for the binding of
substrates in CaFADS appearing as a wide open cavity, it is finely tuned to provide the competent
binding conformation of substrates. In particular, P56, P58 and L98 shape the isoalloxazine site to
place the FMN- and FAD-reacting phosphates in optimal geometry for catalysis.
Keywords: prokaryotic FAD synthase; species-specific traits; adenylyltransferase activity;
head-to-tail organization; isothermal titration calorimetry; site-directed mutagenesis; biosynthesis;
steady-state kinetics
1. Introduction
Prokaryotic FAD synthases (FADSs) are bifunctional and bimodular enzymes that catalyze the
transformation of riboflavin (Vitamin B2, RF) into flavin adenine dinucleotide (FAD) through two
sequential activities; first, an ATP:riboflavin kinase activity (RFK, EC 2.7.1.26) phosphorylates the
RF substrate to produce flavin mononucleotide (FMN) and, then, an ATP:FMN:adenylyltransferase
activity (FMNAT, EC 2.7.7.2) adenylates FMN to yield FAD, with this last reaction being reversible
(Figure 1) [1]. By contrast, these two activities are split in two different proteins in most eukaryotes,
particularly in mammals. The C-terminal module of the prokaryotic FADS family is responsible for the
RFK activity and shares sequence and structural homology with monofunctional eukaryotic RFKs [2–4].
However, the N-terminal module, holding the FMNAT and FAD pyrophosphorylase (FADpp)
activities, widely differs in structure and chemistry from eukaryotic enzymes catalyzing FAD
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biosynthesis [3,5–9]. Instead, it belongs to a structural superfamily (nucleotidyltransferase (NT))
that catalyzes the transfer of nucleotidyl groups to a broad range of substrates. The lack of homology
between prokaryotic and eukaryotic FADSs has pointed to the FMNAT modules of prokaryotic FADSs
as interesting antimicrobial targets [1,10] because interrupting its FMNAT activity in pathogenic
bacteria would not affect FAD biosynthesis in the eukaryote hosts. In this line, the FMNAT module of
bacterial FADSs is already being used as a target in the discovery of antimicrobials [10].
The FADS from Corynebacterium ammoniagenes (CaFADS) has been extensively studied as model of
the prokaryotic FADS family [3,11–15]. Nonetheless, recent studies using other family members, such
as the FADSs from Streptococcus pneumoniae (SpFADS) and Listeria monocytogenes (LmFADS), envisage
species-specific traits that modulate their efficiency. The reported differences among prokaryotic FADSs
include (i) the stabilization or not of quaternary organizations during catalysis, (ii) the differential
modulation of the RFK activity by substrates and products, (iii) the influence of the redox environment in
the occurrence and/or efficiency of the RFK and/or FMNAT activities, and (iv) cooperation in the binding
of substrates and products [14,16–20]. These data exemplify alternative strategies for FMN and FAD
biosynthesis and homeostasis in different bacteria and, in some of them, they point to the FMNAT activity
as a “redox sensor” of the media. These features increase the interest of prokaryotic FADSs in the discovery
of species-specific antimicrobials. Nonetheless, before such applicability is achieved, further knowledge
of differential traits in proteins from different species is required, particularly at the FMNAT activity.
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surface electrostatic potential with the docked substrates. In all panels, docked FMN and ATP 
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respectively, and Mg2+ is shown as a green sphere.
Figure 1. The three-dimensional structure of CaFADS. (a) Cartoon representation of the overall folding
of CaFADS (PDB code: 2x0k) [3] and (b) details of substrates theoretically docked at its binding
N-FMN:adenylyltransferase (FMNAT) active site according to [20]. Side chains evaluated in the
present study (P56, P58 and L98) are shown in Corey, Pauling, Koltun (CPK) sticks with C in magenta.
Structural elements containing them, L3n, α2n and L6n (n denoting secondary structures in the FMNAT
N-terminal domain) and sited at the FMN Re face are also highlighted in magenta. Side chains of N125
and H57 are in CPK sticks with C in salmon. (c) Details of the FMNAT active site surface electrostatic
potential with the docked substrates. In all panels, docked FMN and ATP substrates at the FMNAT
module are shown as CPK sticks with C atoms in brown and violet, respectively, and Mg2+ is shown as
a green sphere.
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No experimental structures have been reported so far for the FMNAT module of any prokaryotic
FADS in complex with substrates or products. However, models for the interaction of CaFADS with
its ATP:Mg2+ and FMN substrates have been built; first, manually, but, more recently, optimized by
docking and molecular dynamics (MD) simulations [3,20]. Together with site-directed mutational
studies on conserved motifs in both the FADS and NT families, these models have pointed to several
residues on the FMNAT module of CaFADS as responsible for the stabilization of ATP and for the
transfer of its nucleotidyl group to FMN [12]. In addition, variations in residues both coating the
flavinic binding site and the channel between the ATP:Mg2+ and FMN binding sites at the FMNAT
module have been claimed as responsible for the variability in requirements for FAD biosynthesis
among prokaryotic proteins from different species [16,17].
In the present study, we evaluate the relevance for catalysis of the native integrity of the binding
cavity for the isoalloxazine of the FMN and FAD substrates in the FMNAT module of CaFADS
(Figure 1) [3,20]. The three residues mutated here—P56, P58 and L98—are in general conserved in
FADSs but not in other NTs, suggesting that they are somehow involved in the interaction with the
FADSs specific substrate, the flavinic substrate. In fact, they are at the binding cavity of the flavinic
substrate isoalloxazine moiety, although according to our molecular models they are not predicted
to directly contact it (Figure 1b). We have produced the single variants P56W, P58W, L98W, L98K
and L98A and the double variant P56A/P58A. These mutations introduce aromaticity and increase
the volume in the corresponding residue (Trp), alter the residue nature (Lys) or include secondary
structure flexibility (the replacement of Pro by Ala). The characterization of these variants indicates
that, in CaFADS, the FMNAT flavin cavity is carefully designed to position the isoalloxazine ring in
such a way that the reacting phosphate atoms of the FMN or FAD substrate situate in the adequate
geometry for the catalysis to take place. These observations also point to the discovery of compounds
able to specifically bind at the isoalloxazine pocket of selected bacterial FADSs as a strategy to develop
new potential antimicrobials.
2. Results
2.1. Occurrence of P56, P58, and L98 Residues in Different Prokaryotic FADSs
Residues P56, P58, and L98, situated at the FMNAT site of CaFADS, are highly conserved in the
prokaryotic FADS family [21]. The two prolines are part of a –FxphP- consensus region (highly conserver
residues are in capital letters, x denotes any residue) (Figure S1a). P58 is conserved in all evaluated
species, but P56 and H57 can be in some cases replaced by other residues. Noticeably, these two
residues are substituted by a Glu and a Ser, respectively, in SpFADS (Figure S1a), an enzyme showing
particular requirements regarding the redox state of the flavin for catalysis. Nonetheless, structures for
both CaFADS and SpFADS show similar conformation for this consensus region, which corresponds to
the β-turn L3n (residues 55–57) and the helix α2n (residues 58–62) in CaFADS (Figure 1). L98, at L6n
(residues 93–102), is not situated in any consensus region, but conservative substitutions of hydrophobic
nature are usually found in this position (Figure S1a) [21]. Noticeably, none of these residues are
conserved in other members of the NT superfamily different from FADSs (Figure S1b), although some
NTs conserve the histidine residue that sits between the prolines in FADSs. Taking into account the
homology between the FMNAT module of FADSs with NTs [22,23], these observations suggest that
these residues must be somehow involved in the flavinic substrate, specific for FADSs, binding.
2.2. Mutations at P56, P58 and L98 Produce Subtle Changes in the Environment of Aromatic Residues
Expression levels of CaFADS variants in Escherichia coli were similar to those for the wild-type
WT, and all of them were purified to homogeneity with a yield of 10–17 mg of protein per g of wet
cells mass. As with the WT enzyme, all variants showed a unique absorption maximum at 279 nm
in the UV–visible spectra [24]. As expected, variants replaced by tryptophan have slightly greater
extinction coefficients than the WT (Table S1). Nonetheless, the increases in ε279 observed for the rest of
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the variants suggest that mutations somehow influence the electronic environment of some aromatic
residues. Far-UV CD spectra of CaFADS variants resembled that of the WT (Figure S2a), suggesting that
mutations do not impact secondary structure. Nonetheless, a slight emphasis on the 207 nm minimum
is observed in the P56W variant, suggesting minor effects in secondary structure elements probably
related to proline removal enhancing local flexibility. Some of the mutations produced an important
impact in the magnitude of the near-UV circular dichroism (CD) spectra (Figure S2b). This was
expected for variants introducing tryptophan residues, but changes in those in which the number of
aromatic amino acids was not modified further support that mutations alter the environment of some
aromatic residues. These observations agree with changes observed in extinction coefficients (Table S1).
Note that, again, the P56W variant exhibits the most significant changes, with the 284 nm minimum
becoming a shoulder. Collectively, these data suggest that the mutations do not compromise the overall
CaFADS folding—they only introduce small and local conformational changes in the environment of
some aromatic side chains.
2.3. P56, P58 and L98 Contribute to Maintain the FMNAT and FADpp Activities of CaFADS and to Modulate
Its RFK Activity
RFK, FMNAT, and FADpp activities of the CaFADS variants were first qualitatively evaluated by
analysis of the reaction products after the incubation of reaction mixtures for 30 min and 2 h (Figure 2).
All variants kept the RFK activity, but in general changes in the amount of RF transformed in the
reaction times were observed when compared with the WT (Figure 2a). Noticeably, none of the variants
was neither capable of catalyzing the transformation of FMN into FAD (Figure 2b) nor of FAD into
FMN (Figure 2c). Thus, substitutions at P56, P58, and L98 override the FMNAT and FADpp activities,
and modulate the RFK activity. Since the CD spectra of the variants discarded protein unfolding, these
mutations must either alter formation of the catalytic complex or prevent the binding of substrates at
the FMNAT site.
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Figure 2. Thin-layer chromatography (TLC) resolution of the products of the transformation of (a)
Riboflavin (RF), (b) FMN and (c) FAD by the CaFADS variants after the incubation of reaction mixtures
for 30′ and/or 2 h at 25 ◦C. Reaction mixtures contained 200 nM of enzyme, 50 µM of flavin and 0.2 mM
of ATP (in a,b) or PPi (in c) in 20 mM 1,4-Piperazinediethanesulfonic acid (PIPES), 10 mM MgCl2,
pH 7.0. Standard markers contain 50 µM of each of the flavins (RF, FMN and FAD) incubated in
similar conditions.
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The kinetic parameters for the RFK activity of the different CaFADS variants were determined
by quantifying product formation on the conversion of RF into FMN as a function of time and at
different concentrations of substrates. Again, and contrary to the WT, chromatographic profiles fail
to detect FAD in these reaction mixtures, confirming the lack of FMNAT activity in these CaFADS
variants. All variants showed inhibition of the RFK activity when varying RF concentration (Figure 3a).
Such behavior is a species-specific trait of CaFADS that has been associated with an excess of RF
substrate and/or FMN and ATP products forming dead-end complexes that prevent the reaction to
take place [13,18,25]. Fitting the data to the equation that describes a substrate inhibition mechanism
provides lower kcat and KmRF values for the variants than those of the WT CaFADS (Table 1). The impact
was greater in the KmRF value that decreases ~10-fold for most of the variants and up to 30-fold for
P56W. Interestingly, with the only exception of P56W, all the variants showed higher Ki values (up to
10-fold), suggesting reduced affinity for the substrate/product inhibitor.
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Figure 3. Michaelis–Menten profiles for the RFK activity of WT (cross, fitting in dotted line), P56W
(filled square), P58W (filled circle), P56A/P58A (filled triangle), L98W (open square), L98K (open circle)
and L98A (open triangle) CaFADS variants (a) as a function of the RF concentration at saturating ATP
(~400 µM) and (b) as a function of ATP at RF concentrations producing ~80% of the maximum activity
experimentally observed in (a). Reactions were followed in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0, at
25 ◦C.
Table 1. Steady-state kinetic parameters (n = 3, value ± SE) for the RFK activity of CaFADS variants.
aram ters obtained in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0 at 25 ◦C.
CaFADS kcat
2,3
(min−1)
KmRF 2,3
(µM)
Ki 2,3
(µM)
kcat/KmRF
(min−1·µM−1)
kcat 3,4
(min−1)
KmATP 4
(µM)
kcat/KmATP 3,4
(min−1·µM−1)
WT 1 408 ± 200 12 ± 3 4.9 ± 3.9 35 ± 21 155 ± 5 28 ± 4 5.5 ± 0.8
P56W 45 ± 5 0.4 ± 0.1 6.5 ± 1.9 125 ± 33 54 ± 2 47 ± 6 1.2 ± 0.2
P58W 98 ± 19 1.3 ± 0.7 39 ± 21 78 ± 43 60 ± 2 52 ± 7 1.2 ± 0.2
P56A/P58A 78 ± 12 0.9 ± 0.4 54 ± 29 87 ± 45 67 ± 4 46 ± 9 1.4 ± 0.3
L98A 138 ± 26 1.5 ± 0.7 32 ± 15 94 ± 48 110 ± 3 30 ± 4 3.6 ± 0.5
L98K 248 ± 34 4.0 ± 1.1 41 ± 13 63 ± 19 84 ± 3 30 ± 5 2.8 ± 0.4
L98W 140 ± 21 1.6 ± 0.6 46 ± 20 85 35 70 ± 4 39 ± 8 1.8 ± 0.4
1 Data from [13]. 2 Parameters obtained at saturating ATP. 3 Strong RF substrate inhibition prevents the determination
of real parameters and these correspond to apparent ones—appkcat and appKm. Estimated errors in appkcat and
appKm can increase up to ±35% due to Ki values in the range of KmRF ones. 4 Parameter estimated when using RF
concentrations producing ~80% of the maximum experimental activity before inhibition is detected according to
Figure 3a.
Profiles obtained for the RFK activity of the variants on the ATP concentration fitted to the
Michaelis–Menten model, as did the WT (Figure 3b). In this case, the variants also showed slightly
lower catalytic efficiencies for the ATP substrate, due to the up to 2.5-fold lower kcat and the up to
1.8-fold increase in KmATP, when compared to WT CaFADS (Table 1).
These data indicate, first, that the introduced mutations at P56, P58 and L98 residues abolish the
CaFADS FMNAT activity and, second, that the conformation of the FMNAT substrates binding site
cavity is somehow related to the binding/exit of substrates/products at the RFK site of the enzyme.
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2.4. P56, P58 and L98 Contribute to the Binding of Flavinic Substrates/Products at the FMNAT Site of CaFADS
Since the substitutions studied here nullified the CaFADS ability to transform FMN into FAD, we
aimed to assess whether this was a consequence of substrates unable to bind at the FMNAT active site or
the interaction happening in an unproductive conformation. We first used differential spectroscopy to
qualitatively evaluate the impact of the mutations in the flavin:CaFADS interaction. Taking advantage
of the fact that in the absence of adenine nucleotide, both FMN and FAD exclusively bind to the
FMNAT cavity [24], we were able to evaluate the impact of the mutations in the binding of flavins at
the FMNAT site. All the variants produced difference spectra after incubation with FMN. However,
they showed differences, mainly in magnitude, with regard to the WT, indicating that the mutations
alter the FMN isoalloxazine electronic environment within the FMNAT site (Figure S3). The magnitude
of the difference spectra for P56W, the double P56A/P58A, L98K and particularly L98W variants were
significantly lower when compared to the WT protein. Moreover, the FMN concentrations required for
achieving the maxima difference spectra signals were significantly higher for variants P56W, P58W and
L98W. On the contrary, the titration of CaFADS variants with FAD hardly produced difference spectra,
the ∆ε values observed being negligible (Figure S4), indicating that all the introduced mutations have
an important deleterious effect in the placement of the FAD isoalloxazine ring inside its binding cavity.
We then used isothermal titration calorimetry (ITC) to quantitatively evaluate the effect of the
mutations on ligand binding. Under our assay conditions, a single binding site, situated at the FMNAT
cavity, has been reported for the titration of WT CaFADS with either FMN or FAD by ITC [24,25]. When
our variants were similarly evaluated, no binding thermograms were detected for the titrations of L98K
with neither FMN nor FAD, and of L98A with FAD. The rest of the variants kept the same stoichiometry
as the WT—one binding site (Figure 4). Derived dissociation constants, Kd, from these experiments
indicated that WT CaFADS binds FAD stronger than FMN (1.1 µM and 7.1 µM, respectively) (Table 2).
On the contrary, mutations studied here increased the FMNAT module affinity for FMN (with KdFMN
values up to 4-fold lower for P56W and more than 10-fold lower for the rest of the variants) and
decreased the protein affinity for FAD (KdFAD values increased by at least 2-fold, and up to 6 for P56W)
(Figure 4a,b, Table 2). The different, and apparently opposite, effects of mutations in FMN and FAD
binding has to be understood in the context of FAD being formed by a FMN moiety plus an adenine
monophosphate (AMP) moiety that must bind in the ATP binding site of the FMNAT module. Thus,
FAD binding requires the simultaneous placement of its flavin and adenine moieties at their respective
cavities. The bipartite binding required for FAD would be beyond its reduced ability, when compare to
FMN, to fit in a distorted cavity. In fact, contrary to the WT [24], variants exhibited a considerably low
enthalpic contribution for FMN and FAD binding, while a favorable entropic contribution became the
driving force (Figure 5a,b, Table S2). These observations confirmed that the introduced mutations alter
not only the FAD but also the FMN binding modes at the FMNAT site of CaFADS.
Table 2. Dissociation constants (n = 3, mean ± SD) as determined by ITC for the binding of FMN, FAD,
and ATP to the CaFADS variants. Data obtained at 25 ◦C in 20 mM PIPES, pH 7.0, at the indicated
MgCl2 concentrations. (n.d. interaction not detected during titration).
CaFADS Kd FMN (µM) Kd FAD (µM) Kd ATP (µM)
10 mM MgCl2 + + -
WT 7.1 ± 0.4 1.1 ± 0.1 48 ± 7
P56W 1.7 ± 0.1 8.3 ± 0.8 44 ± 5
P58W 0.50 ± 0.03 2.6 ± 0.2 16 ± 1
P56A/P58A 0.35 ± 0.02 1.9 ± 0.1 21 ± 3
L98A 0.23 ± 0.03 n.d. 7 ± 5
L98K n.d. n.d. 82 ± 21
L98W 0.42 ± 0.02 3.8 ± 0.1 47 ± 7
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Figure 5. Thermodynamic dissections for the i teraction of CaFADS variants with (a) FMN, (b) FAD
and (c) ATP. he Gibbs energy (∆G), enthalpy (∆H), and entropy (−T∆S) ontributions to the binding
are represented in dark grey, light grey and whit bars, respectively. Experiments were carried out
at 25 ◦C in 20 mM PIPES, pH 7.0, for ATP, containing 10 mM MgCl2 in addition for FMN and FAD
titrations. SD values in ∆G, ∆H and −T∆S are in general ±1 kcal/mol for FMN and FAD binding, and
they can considerably increase for ATP binding (Table S2).
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ITC was also used to evaluate ATP binding. In this case, titrations were carried out in the absence
of MgCl2, since under these conditions, the binding of ATP only takes place at the CaFADS FMNAT
module (cation induces a second binding site at the RFK module) [24]. All variants kept the 1:1 binding
stoichiometry reported for WT CaFADS in these conditions, but two trends in behavior regarding
thermodynamic parameters were observed. Substitutions at L98 and the replacement of P56 by Trp
only mildly modulated the parameters for ATP binding when compared to the WT, exhibiting similar
thermodynamic profiles and only slightly decreasing the affinity for the nucleotide (Figure 4c, Table 2
and Table S2). On the contrary, the P58W and P56A/P58A variants exhibited lower KdATP values
and altered the thermodynamic profile for ATP binding, having a negative impact on the enthalpic
contribution and converting the entropic one into slightly favorable (Figure 5c and Table S2). According
to these results, mutations introduced at P58 compromise ATP binding at the FMNAT module of
CaFADS more so than those at P56, while residue L98 hardly influences the nucleotide interaction (in
agreement with its situation far from the ATP binding site).
3. Discussion
All substitutions introduced here at P56, P58 and L98 in CaFADS override the enzyme ability to
catalyze the FMNAT and FADpp activities occurring at the FMNAT module (Figure 2b,c). Nonetheless,
all variants bind ATP, and only the L98K and L98A mutations totally prevent the binding of FMN and/or
FAD at this module (Figure 4, Table 2). However, thermodynamic profiles for ligand binding indicate
that most mutations remarkably impact the FMN, FAD and ATP binding mode (Figure 5a,b, Table
S2). In agreement, difference spectra for flavins binding indicate subtle changes in the environment
of the flavinic ring of FMN among variants, and the lack of accommodation of the flavinic ring of
FAD within its cavity for all of them (Figures S3 and S4). Therefore, mutations at P56, P58 and L98
negatively influence the ability of CaFADS to accommodate the isoalloxazine ring of flavinic substrates
within its binding site at the FMNAT module.
Docking models for the binding of the FMN and ATP:Mg2+ substrates at the FMNAT active site in
CaFADS [20] situate the isoalloxazine ring in a hydrophobic pocket formed by F54, P58, F62, F93, L98,
Y106 and F128, but only the side chains of F54, F62, F93 and Y106 are expected to directly contact the
isoalloxazine (Figures 1c and 6). P56, despite not being part of the cavity, forms together with P58 and
H57, a highly conserved motive (Figure S1). This motive contributes to the side chain of this histidine
approaching the phosphates of substrates from the opposite site of residue N125—the amide group
of which has been shown to be key to providing a hydrogen bond to position the phosphates [12,20]
(Figures 1b and 6a). We observe different impacts in flavin binding and in environments of aromatic
residues as a function of both the modified residue and the nature of the substitution (Figure 5a,b,
Figures S2b, S3 and S4, Table 2 and Table S2), in turn suggesting the conformational rearrangements of
L3n, α2n and/or L6n, and/or of their environment (Figure 1c).
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 9 of 15 
 
of the substitution (Figure 5a,b, Figures S2b, S3 and S4, Table 2 and Table S2), in turn suggesting the 
conformatio al rearrangements of L3n, 2n and/or L6n, and/or of their environment (Figures 1c).  
 
Figure 6. Molecular surface of the active site of the FMNAT module of CaFADS (a) in WT and (b) in a 
P56W in silico model with the substituted tryptophan in white. Surfaces of residues F54, F62, F93, 
Y106 and F128 coating the isoalloxazine binding site are shown in yellow. Substrates are docked 
according to [20]. Rest of color codes as in Figure 1. 
P56 and P58 at L3n (residues 55–57) and α2n (residues 58–62), respectively, of the FMNAT 
module (Figure 1c), appear to confer rigidity to these structural elements at the entrance of the 
isoalloxazine cavity. Their substitution, particularly in the P56A/P58A variant, must favor flexibility 
in L3n and 2n (in agreement with the changes in near-UV CD spectra (Figure S1b)), which also 
contain H57 and F62 (putatively involved in phosphates and isoalloxazine interaction, respectively). 
The replacement of P58 by the bulky tryptophan will in addition presumably reduce the size of the 
isoalloxazine entrance and binding sites (Figure 6). Altogether, changes in these structural elements 
can explain why the P56 and P58 mutations considerably alter FMN and FAD thermodynamic 
contributions to the binding (Figure 5a,b, Table S3), as well as the protein capability to internalize 
their isoalloxazine rings, particularly the one of the large molecule of FAD (Figures S3 and S4). 
Moreover, they can similarly explain why substitutions at P56 and, particularly, P58 modulate the 
thermodynamic contributions to ATP binding (Figure 5c, Table 2 and Table S2), suggesting that 
these Pro residues confer a particular conformation to the L3n–α2n motif that contributes to H57 
approaching the active site crevice. In this way, H57 can contribute to stabilize the negative charge of 
phosphates of ATP:Mg2+ and FMN at the active site during catalysis. 
Our data also show a drastic impact in flavins binding when substituting L98—the replacement 
of which by Lys and Ala produces variants unable to interact with FMN and FAD (Table 2). 
Noticeably, in the WT enzyme, the L98 side chain, at L6n, points to the opposite side of the 
isoalloxazine cavity. Thus, it sits among L1n (residues 6–47), L6n (residues 93–102) and 4n 
(residues 102–111), surrounded by T6, I92, E97, F109 and L110 (Figure S5). The introduced changes 
in charge, hydrophobicity and/or size will surely change the conformation in this region. This in turn 
can produce conformational reorganizations in L1n and L6n loops, as predicted from the changes 
observed in near-UV CD spectra (Figure S5). Induced changes, particularly in L6n, must be critical to 
shape the isoalloxazine cavity. Therefore, the nature of the P56, P58 and/or L98 side chains in 
CaFADS is important to shape a cavity able to internalize the isoalloxazine moiety of the flavinic 
substrates at its FMNAT site. The fact that the FMNAT activity is not observed even for variants 
apparently able to internalize the isoalloxazine of FMN (Figure S3) indicates that the nature of these 
residues is also key to achieving an adequate geometry at the active site for catalysis. In CaFADS, the 
adenylylation of FMN occurs via a direct nucleophilic attack by the 5'-P of FMN on the α-P of ATP, 
as also described for other members of the NT superfamily [12,26]. This mechanism requires the 
reacting phosphates of substrates to get close enough for the nucleophilic attack to take place. The 
structure of CaFADS reveals an open FMNAT active site [3], where the competent binding of 
substrates must be carefully driven by residues at their binding cavities. In this way, H28 and H31 
are key residues that accommodate the adenine moiety of ATP in such a way that its phosphates are 
Figure 6. Molecular surface of the active site of the FMNAT module of CaFADS (a) in WT and (b) in a
P56W in silico model with the substituted tryptophan in white. Surfaces of residues F54, F62, F93, Y106
and F128 coating the isoalloxazine binding site are shown in yellow. Substrates are docked according
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P56 and P58 at L3n (residues 55–57) and α2n (residues 58–62), respectively, of the FMNAT module
(Figure 1c), appear to confer rigidity to these structural elements at the entrance of the isoalloxazine
cavity. Their substitution, particularly in the P56A/P58A variant, must favor flexibility in L3n and α2n
(in agreement with the changes in near-UV CD spectra (Figure S1b)), which also contain H57 and
F62 (putatively involved in phosphates and isoalloxazine interaction, respectively). The replacement
of P58 by the bulky tryptophan will in addition presumably reduce the size of the isoalloxazine
entrance and binding sites (Figure 6). Altogether, changes in these structural elements can explain
why the P56 and P58 mutations considerably alter FMN and FAD thermodynamic contributions to the
binding (Figure 5a,b, Table S3), as well as the protein capability to internalize their isoalloxazine rings,
particularly the one of the large molecule of FAD (Figures S3 and S4). Moreover, they can similarly
explain why substitutions at P56 and, particularly, P58 modulate the thermodynamic contributions to
ATP binding (Figure 5c, Table 2 and Table S2), suggesting that these Pro residues confer a particular
conformation to the L3n–α2n motif that contributes to H57 approaching the active site crevice. In this
way, H57 can contribute to stabilize the negative charge of phosphates of ATP:Mg2+ and FMN at the
active site during catalysis.
Our data also show a drastic impact in flavins binding when substituting L98—the replacement
of which by Lys and Ala produces variants unable to interact with FMN and FAD (Table 2). Noticeably,
in the WT enzyme, the L98 side chain, at L6n, points to the opposite side of the isoalloxazine cavity.
Thus, it sits among L1n (residues 6–47), L6n (residues 93–102) and α4n (residues 102–111), surrounded
by T6, I92, E97, F109 and L110 (Figure S5). The introduced changes in charge, hydrophobicity and/or
size will surely change the conformation in this region. This in turn can produce conformational
reorganizations in L1n and L6n loops, as predicted from the changes observed in near-UV CD spectra
(Figure S5). Induced changes, particularly in L6n, must be critical to shape the isoalloxazine cavity.
Therefore, the nature of the P56, P58 and/or L98 side chains in CaFADS is important to shape a cavity
able to internalize the isoalloxazine moiety of the flavinic substrates at its FMNAT site. The fact that
the FMNAT activity is not observed even for variants apparently able to internalize the isoalloxazine
of FMN (Figure S3) indicates that the nature of these residues is also key to achieving an adequate
geometry at the active site for catalysis. In CaFADS, the adenylylation of FMN occurs via a direct
nucleophilic attack by the 5’-P of FMN on the α-P of ATP, as also described for other members of the
NT superfamily [12,26]. This mechanism requires the reacting phosphates of substrates to get close
enough for the nucleophilic attack to take place. The structure of CaFADS reveals an open FMNAT
active site [3], where the competent binding of substrates must be carefully driven by residues at their
binding cavities. In this way, H28 and H31 are key residues that accommodate the adenine moiety of
ATP in such a way that its phosphates are addressed towards the active site, where N125 has been
shown to be directly implicated in its stabilization to ensure approaching the FMN phosphate [12,20].
Here, we similarly show how the properties of the isoalloxazine binding cavity (to which P56, P58
and L98 contribute) are key to bind the FMN in a conformation that favors its phosphate group to
situate at the active site. Thus, the internalization of the isoalloxazine ring and the formation of the
competent complex for catalysis at the FMANT site of CaFADS are highly sensitive to subtle changes
in the conformation of the isoalloxazine binding cavity, indicating that there is fine regulation of the
binding of the flavin substrate for efficient FMNAT catalysis. Such an idea is in line with former studies
showing that some FADSs are only able to internalize and, as a consequence, to transform flavins at
their FMNAT site when they are in their reduced state [17], while in others, the transformation of both
oxidized or reduced flavins occurs with different catalytic efficiencies [16].
Furthermore, the main effect of the mutations studied here occurs in the binding of substrates and
activity at the FMNAT site, and they also modulate the kinetic parameters for the RFK activity taking
place at the RFK C-terminal module of the protein (Figures 2a and 3, Table 1). Such an observation
agrees with previous reports indicating that during catalysis in CaFADS, (i) the FMNAT and RFK
modules influence the catalytic efficiency of each other [13,15] and (ii) a dimer-of-trimers organization
is produced, sitting the RFK module of one protomer and the FMNAT module of the contiguous
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protomer within each trimer in a head-to-tail organization (Figure 7a) [3,14]. Structural analyses of
the binding of ligands to the RFK and FMNAT sites (by using both X-ray diffraction crystallography
and docking/MD simulations) have shown large conformational changes in several loops of the RFK
module (particularly L1c and L4c) and the relative pivoting of the head-to-tail RFK and FMNAT
modules [4,20]. Noticeably, in this organization, the open and free binding site at the RFK module
of one protomer is in part covered by α2n and L4n of the contiguous protomer [4] (Figure 7b). Thus,
when, on ligands binding at the RFK site, L1c and L4c of the RFK module close its active site cavity,
the FMNAT region formed by L3n (containing P56), α2n (containing P58) and L4n of the contiguous
protomer need to be displaced, envisaging the approach of L1c towards L6n (containing L98) (compare
molecular surfaces in Figure 7b,c) [4]. Such observations agree with P56, P58 and L98 substitutions
modulating ligand binding, kinetic and substrate inhibition parameters at the RFK site (Figure 3 and
Table 1), effects that can only be explain within the head-to-tail organization. Since, as mentioned
above, these substitutions influence conformation at the FMNAT module (Figure S2b), this study
further contributes to identifying L3n, α2n and L6n as those regions where the pivoting of the RFK
module on the FMNAT one must be produced for substrates access to the RFK active site.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 11 of 15 
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were dialyzed in 20 mM PIPES, pH 7.0, and storage at −20 °C until used.  
4.2. Spectroscopic Analysis 
Spectroscopic measurements were carried out following previously established conditions and 
protocols [12,25]. UV–visible absorption spectra were recorded in a Cary 100 spectrophotometer 
(Agilent Technologies, Santa Clara, CA, USA). Experimental extinction coefficients at 279 nm (ε279) for 
each variant were determined based on the Gill and von Hippel method [27]. In short, the UV–visible 
absorbance spectrum of the protein was recorded. Then samples were denatured with guanidinium 
hydrochloride (6 M in 20 mM sodium phosphate, pH 6.5). Then, the absorbance spectrum of the 
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maximum by using the native protein spectrum before denaturation. Difference spectroscopy 
Figure 7. Quaternary structure assembly of CaFADS. (a) Cartoon representation of a trimer of the
dimer-of-trimers assembly reported for CaFADS. Docked substrates of the FMNAT activity are shown
in protomer A1. Cartoon models of the head-to-tail interface of the FMNAT module of protomer A1
(blue) with (b) the open conformation of the RFK module (green) in protomer A2 (PDB code: 2x0k) and
(c) when replacing the conformation of the RFK module in protomer A1 by the closed one (brown)
elicited on the binding of the products of the RFK activity (PDB code: 5a89); RFK modules are shown
as cartoon and surface on left and right panels, respectively. F62 at the interface between head-to-tail
modules is shown as magenta sticks. In (c), FMN and ADP products of the RFK activity are shown in
CPK sticks with C in yellow and grey, respectively. Other color codes as in Figures 1 and 2.
In conclusion P56, P58 and L98 contribute to shape the conformation of the binding site for
the flavins at the FMNAT site of CaFADS. The conformation of the isoalloxazine binding cavity in
the WT protein appears particularly designed and tuned for flavin internalization, a feature that in
turns appears critical to orientate the reactive atoms of the FMN and ATP:Mg2+ (or FAD and PPi)
substrates in a competent geometry for the FMNAT (or FADpp) catalysis to take place. Our data
suggest the contributions of (i) P56 and P58 to reduce the flexibility of L3n and α2n motives, and of
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(ii) L98 to shape the cavity through the conformation of L6n as key features for FMNAT catalysis
to occur in CaFADS. In addition, they also provide further evidence of the structural crosstalk of
different protomers within a quaternary CaFADS assembly, not reported so far for any other FADS
species, to regulate the RFK catalysis of this enzyme. Finally, our observations further contribute to
the understanding of the mechanisms of substrate binding and catalysis in a bacterial protein family
considered as an antimicrobial target, particularly pointing to the isoalloxazine binding pocket as a
good receptor site for such compounds to prevent the FMNAT activity.
4. Materials and Methods
4.1. Biological Material
The P56W, P58W, L98A, L98K, L98W and P56A/P58A mutations were introduced by site-directed
mutagenesis on the pET28a-CaFADS plasmid by Mutagenex® (this company also sequenced the
resulting mutated plasmids to confirm they contained the desired mutations). The mutated
pET28a-CaFADS plasmids were used to transform BL21(DE3) E. coli cells. Transformants were
grown as previously described and CaFADS variants were purified following the same protocol as for
the WT enzyme [15]. Protein purity was assessed by SDS-PAGE. Purified samples were dialyzed in
20 mM PIPES, pH 7.0, and storage at −20 ◦C until used.
4.2. Spectroscopic Analysis
Spectroscopic measurements were carried out following previously established conditions and
protocols [12,25]. UV–visible absorption spectra were recorded in a Cary 100 spectrophotometer
(Agilent Technologies, Santa Clara, CA, USA). Experimental extinction coefficients at 279 nm (ε279) for
each variant were determined based on the Gill and von Hippel method [27]. In short, the UV–visible
absorbance spectrum of the protein was recorded. Then samples were denatured with guanidinium
hydrochloride (6 M in 20 mM sodium phosphate, pH 6.5). Then, the absorbance spectrum of the
denatured sample was recorded and its concentration was calculated considering the theoretical
extinction coefficient determined using the amino acid sequence. This concentration, taking into
account the protein dilution in the denaturation process, was then used to determine ε279 at the
protein maximum by using the native protein spectrum before denaturation. Difference spectroscopy
measurements were carried out in 20 mM PIPES, 10 mM MgCl2, pH 7.0, with saturating concentrations
of ligands. Circular dichroism (CD) spectra were recorded using a Chirascan spectropolarimeter
(Appl. Phot. Ltd., Leatherhead, Surrey, UK) at 25 ◦C. Samples containing 5 µM CaFADS in 5 mM PIPES,
10 mM MgCl2, pH 7.0 and 20 µM CaFADS in 20 mM PIPES, 10 mM MgCl2, pH 7.0, were used in the
far-UV (cuvette path length, 0.1 cm) or near-UV CD (path length, 0.4 cm), respectively.
4.3. Qualitative Detection of RFK, FMNAT and FADpp Activities
RFK and FMNAT activities were qualitatively assayed by the incubation of enzymes with
substrates and separation of flavins (substrates and products) from reaction mixtures using TLC on
Silica Gel SIL-G-25 plates (20 × 20 cm, thickness 0.25 mm) as previously described [12,21]. The reaction
mixtures, containing 50 µM RF/FMN (or FAD), 0.2 mM ATP (or PPi) and ~200 nM of CaFADS in 20 mM
PIPES, 10 mM MgCl2, pH 7.0 (conditions that allow the three reactions catalyzed by WT CaFADS to
take place [24]), were incubated for 30 min and 2 h at 37 ◦C. Reactions were stopped by boiling the
preparations for 5 min. Flavin spots were visualized under UV light.
4.4. Quantitative Determination of Steady-State Kinetics Parameters for the RFK Activity
The CaFADS RFK activity was measured at 25 ◦C in 500 µL of 20 mM PIPES, 0.8 mM MgCl2, pH 7.0,
containing 0.5–45 µM RF and 10–450 µM ATP. Reactions were initiated by the addition of ~20 nM of
enzyme. After 1 min incubation at 25 ◦C, the reactions were stopped by boiling the mixtures for 5 min.
The composition of flavins in the supernatant was determined using an Alliance HPLC system (Waters,
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Milford, MA, USA) equipped with a 2707 autosampler and a HSST3 column (4.6 × 150 mm, 3.5 µm,
Waters) preceded by a pre-column (4.6 × 20 mm, 3.5 µm, Waters). The chromatography was developed
at 1 mL/min with a 6 min isocratic program of methanol 40% (v/v) in 5 mM ammonium acetate (pH 6.0).
Detection of flavins was carried out using a 2475 Multi λ fluorescence detector (Waters), excitation
wavelength of 470 nm and emission wavelength of 530 nm. Under these conditions, the retention
times for the flavins were 2.3 min for FAD, 3.4 min for FMN, and 5.5 min for RF. The flavinic products
of the reaction were identified by their retention times and quantified through their corresponding
standard curves obtained under the same conditions. Controls containing free flavins in the absence
of the enzyme were treated similarly to reaction samples to discard flavin degradation during RFK
activity determination. The kinetic data obtained for one substrate at saturating concentrations of the
second one (as nmol of flavin transformed per min) were interpreted using the Michaelis–Menten
kinetic model, obtaining kcat and Km with errors of ±10%. In case of inhibition, the experimental data
were fitted to a model describing the substrate inhibition of a bi-substrate mechanism [28]. In these
situations, errors in apparent Km and kcat (appKm and appkcat) increased with the inhibition constant
(Ki) value getting closer to KmS. Reaction mixtures were evaluated in triplicates, and final results are
expressed as the standard error of the fitted value (value ± SE).
4.5. Isothermal Titration Calorimetry (ITC)
Measurements were carried out using a VP-ITC microcalorimeter (MicroCal LLC, Northampton,
MA, USA) thermostated at 25 ◦C. Ligand (200 µM FMN or FAD, and 300 µM ATP) and enzymes
(~20 µM of CaFADS) were dissolved in 20 mM PIPES, pH 7.0 (in presence of 10 mM MgCl2 for the
flavins), and degassed prior to titration. Up to 28 injections of 4 µL of ligand were added to the sample
cell (1.4109 mL) containing the enzyme and then mixed via the rotating (1000 rpm) stirrer syringe.
The association constant (Ka), the enthalpy change (∆H) and the stoichiometry (N) were obtained
through non-linear regression of the experimental data to a home-derived model for one binding site
implemented in Origin 7.0 (OriginLab, Northampton, MA, USA) [12,24]. The dissociation constant (Kd),
the free energy change (∆G), and the entropy change (∆S) were obtained from basic thermodynamic
relationships. Experiments were performed in triplicate. Results are expressed as the standard
deviation of the mean (±SD).
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Abbreviations
ATP Adenosine 5′-triphosphate
CD Circular dichroism
FAD Flavin adenine dinucleotide, Riboflavin 5′-adenosine diphosphate
FADpp FAD pyrophosphorylase
FADS FAD synthase
FMN Flavin mononucleotide, Riboflavin 5′-phosphate
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FMNAT ATP:FMN adenylyl transferase
HPLC High performance chromatography
ITC Isothermal titration calorimetry
MD Molecular dynamics
NT Nucleotidyl transferase
PIPES 1,4-Piperazinediethanesulfonic acid
RF Riboflavin
RFK ATP:riboflavin kinase
TLC Thin-layer chromatography
UV Ultraviolet
WT Wilde type
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